Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/47388
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Simsek, Fikri Selcuk | - |
dc.contributor.author | Yuksel, Dogangun | - |
dc.contributor.author | Yaylali, Olga | - |
dc.contributor.author | Aslan, Halil Serdar | - |
dc.contributor.author | Kilicarslan, Emel | - |
dc.contributor.author | Bir, Ferda | - |
dc.contributor.author | Ugurlu, Erhan | - |
dc.date.accessioned | 2023-01-09T21:24:17Z | - |
dc.date.available | 2023-01-09T21:24:17Z | - |
dc.date.issued | 2021 | - |
dc.identifier.issn | 1867-1071 | - |
dc.identifier.issn | 1867-108X | - |
dc.identifier.uri | https://doi.org/10.1007/s11604-021-01155-z | - |
dc.description | Aslan, Halil Serdar/0000-0002-5255-8618; Can, Fatma Ezgi/0000-0002-1953-7735 | en_US |
dc.description.abstract | Purpose Sometimes, characterization of pleural effusion (PE) can be challenging especially in patients whom invasive procedures/recurrent invasive procedures cannot be performed. The main purpose of the study is to answer this question, Can F-18-FDG-PET/CT contribute to reduction in the number of invasive procedures or patients undergoing to invasive procedures? Results may increase the effectiveness of patient management by facilitating clinical decision-making, especially in patients who cannot undergo invasive/recurrent invasive procedures. Methods Sixty-seven patients' F-18-FDG-PET/CT, pleural fluid cytologies (PFCs) and, if any, pleural biopsies were re-assessed. If patient's PFC/biopsy was malignant, effusion was considered as malignant. If two consecutive PFCs were negative in patients without biopsy, effusion was considered as benign. Characterization was based on consensus with baseline/follow-up F-18-FDG-PET/CT and clinical parameters in patients with one negative PFC (n = 6). Results None of the F-18-FDG-PET/CT parameters could characterize PE alone. However, if PE maximum standardized uptake value (SUVmax) > 1.3 or PE SUVmax/mean standardized uptake value of mediastinal blood pool (MBP SUVmean) > 1.2 was combined with at least one of the following, specificity and positive predictive value (PPV) were 100%, accuracy was around 90%. Diffuse-nodular/nodular pleural thickness, post-obstructive atelectasis, nodule/mass with SUVmax > 2.5 in lung, multiple pulmonary nodules. All 29 patients who had SUVmax > 1.3 together with at least one of the mentioned four parameters diagnosed malignant pleural effusion (MPE). However, sensitivity and negative predictive value (NPV) were still insufficient. Conclusion Patients who have contraindications for invasive diagnostic methods, and meet the aforementioned criteria may be considered as MPE primarily. On the other hand, if PE SUVmax < 1.3 or PE SUVmax/MBP SUVmean < 1.2 with the negativity of the all four parameters mentioned above, it is difficult to say that this can be considered as benign pleural effusion (BPE) according to our results. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Pleural Effusion | en_US |
dc.subject | F-18-Fdg-Pet | en_US |
dc.subject | Ct | en_US |
dc.subject | Combined Approaches | en_US |
dc.title | Can Pet/Ct Be Used More Effectively in Pleural Effusion Evaluation | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 39 | en_US |
dc.identifier.issue | 12 | en_US |
dc.identifier.startpage | 1186 | en_US |
dc.identifier.endpage | 1194 | en_US |
dc.department | Pamukkale University | en_US |
dc.authorid | Aslan, Halil Serdar/0000-0002-5255-8618 | - |
dc.authorid | Can, Fatma Ezgi/0000-0002-1953-7735 | - |
dc.identifier.doi | 10.1007/s11604-021-01155-z | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.authorwosid | Arslan, Muhammet/Hkf-5218-2023 | - |
dc.authorwosid | Yüksel, Doğangün/Aaa-6085-2021 | - |
dc.authorwosid | Can, Fatma Ezgi/Jsl-7718-2023 | - |
dc.authorwosid | Aslan, Halil/Ltf-3719-2024 | - |
dc.authorwosid | Bir, Ferda/Hge-9200-2022 | - |
dc.identifier.pmid | 34165683 | en_US |
dc.identifier.pmid | 34165683 | - |
dc.identifier.scopus | 2-s2.0-85120397226 | en_US |
dc.identifier.scopus | 2-s2.0-85120397226 | - |
dc.identifier.wos | WOS:000665829400001 | - |
dc.identifier.scopusquality | Q2 | - |
dc.description.woscitationindex | Science Citation Index Expanded | - |
dc.identifier.wosquality | Q3 | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | Article | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.01. Surgical Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
2
checked on Apr 26, 2025
WEB OF SCIENCETM
Citations
3
checked on Apr 29, 2025
Page view(s)
132
checked on Apr 14, 2025
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.